BERZIGOTTI, ANNALISA
 Distribuzione geografica
Continente #
NA - Nord America 2.274
EU - Europa 1.497
AS - Asia 459
AF - Africa 79
SA - Sud America 5
OC - Oceania 3
Totale 4.317
Nazione #
US - Stati Uniti d'America 2.272
GB - Regno Unito 422
SE - Svezia 228
DE - Germania 202
CN - Cina 190
IT - Italia 180
VN - Vietnam 159
UA - Ucraina 99
IN - India 86
IE - Irlanda 81
RU - Federazione Russa 64
FR - Francia 57
CH - Svizzera 55
EE - Estonia 37
ZA - Sudafrica 36
TG - Togo 28
BG - Bulgaria 24
BE - Belgio 10
HR - Croazia 10
JO - Giordania 7
CI - Costa d'Avorio 6
GR - Grecia 6
JP - Giappone 5
CZ - Repubblica Ceca 4
ES - Italia 4
FI - Finlandia 4
IR - Iran 4
LB - Libano 4
NG - Nigeria 4
NL - Olanda 4
SC - Seychelles 4
AU - Australia 3
BR - Brasile 3
AT - Austria 2
CA - Canada 2
SG - Singapore 2
BY - Bielorussia 1
CL - Cile 1
DK - Danimarca 1
EC - Ecuador 1
EG - Egitto 1
HK - Hong Kong 1
PT - Portogallo 1
RO - Romania 1
TR - Turchia 1
Totale 4.317
Città #
Southend 377
Fairfield 317
Chandler 316
Ashburn 176
Seattle 142
Woodbridge 142
Houston 131
Wilmington 125
Dong Ket 123
Cambridge 108
Princeton 95
Dublin 81
Ann Arbor 78
Jacksonville 58
Bern 53
Nanjing 41
Westminster 39
Bremen 34
Padova 34
Bologna 28
Lomé 28
San Diego 26
Sofia 24
Shenyang 22
Berlin 21
Jinan 21
Saint Petersburg 21
Florence 18
Nanchang 18
Turin 15
Medford 14
Hebei 13
Redwood City 13
Des Moines 12
New York 12
Beijing 10
Boardman 10
Brussels 10
Changsha 9
Dearborn 9
Mülheim 9
Tianjin 9
Milan 8
Amman 7
Taiyuan 7
Abidjan 6
Kuban 6
Ningbo 6
Paris 6
Bühl 5
Chicago 5
Jiaxing 5
Los Angeles 5
Norwalk 5
Tokyo 5
Verona 5
Abeokuta 4
Hangzhou 4
Helsinki 4
Kunming 4
Kyiv 4
Mahé 4
Pune 4
Amsterdam 3
Falls Church 3
Haikou 3
London 3
Mountain View 3
Olalla 3
São Paulo 3
Taizhou 3
Washington 3
Buffalo 2
Cagliari 2
Costa Mesa 2
Finale Emilia 2
Frankfurt Am Main 2
Guangzhou 2
Kiev 2
Kilburn 2
Lanzhou 2
Phoenix 2
Pomigliano D'arco 2
Rome 2
San Francisco 2
San Jose 2
San Venanzo 2
Toronto 2
Zhengzhou 2
Andover 1
Ardabil 1
Athens 1
Barcelona 1
Bochum 1
Bolton 1
Brno 1
Bronx 1
Cairo 1
Canberra 1
Centurion 1
Totale 3.023
Nome #
Chronic endurance exercise training prevents aging-related cognitive decline in healthy older adults: a randomized controlled trial. 169
Circulating and hepatic endocannabinoids and endocannabinoid-related molecules in patients with cirrhosis 163
Age dependency of regional impedance indices regardless of clinical stage in patients with cirrhosis of the liver 125
Primary prophylaxis with nadolol in cirrhotic patients: Doppler patterns of splanchnic hemodynamics in good and poor responders. 124
Long-term beta-blockade shortens Qt interval prolongation in patients with liver cirrhosis 123
A SPLEEN STIFFNESS MEASUREMENT-BASED MODEL FOR THE RECOGNITION OF HIGH RISK VARICES: BAVENO VI CRITERIA AND BEYOND 119
Postprandial splanchnic haemodynamic changes in patients with liver cirrhosis and patent paraumbilical vein 117
Octreotide in the outpatient therapy of cirrhotic chylous ascites: a case report. 117
Peliosis hepatis as an early histological finding in idiopathic portal hypertension: a case report. 116
null 115
A spleen stiffness measurement-based model for the recognition of high risk varices: Baveno VI criteria and beyond 112
Prognostic value of a single HVPG measurement and Doppler-ultrasound evaluation in patients with cirrhosis and portal hypertension 109
Torsade de pointes” during amiodarone infusion in cirrhotic woman with the prolonged QT interval. 107
Effect of chronic beta-blockade on QT interval in patients with liver cirrhosis. 106
Liver hemangioma and vascular liver diseases in patients with systemic lupus erythematosus. 105
Non-invasive measurement of HVPG using graph analysis based on dynamic contrast-enhanced ultrasound with ESAOTE MyLab: The CLEVER Study. 104
Renovascular impedance correlates with portal pressure in patients with liver cirrhosis 104
Routine blood tests? Helping you live(r) longer! 103
In portal hypertensive cirrhotic patients abdominal porto-systemic collaterals at ultrasound identify a group of patients at high risk of death 103
Endocannabinoids and endocannabinoid-related molecules in patients with liver cirrhosis 102
EFSUMB Guidelines and Recommendations on the Clinical Use of Liver Ultrasound Elastography, Update 2017 (Short Version) 101
Reduced prevalence of ischemic events and abnormal supraortic flow patterns in patients with liver cirrhosis. 99
Clinical significance of worsening portal hypertension during long-term medical treatment in patients with cirrhosis who had been classified as early good-responders on haemodynamic criteria. 97
New abdominal collaterals at ultrasound: a clue of progression of portal hypertension 96
EFSUMB Guidelines and Recommendations on the Clinical Use of Liver Ultrasound Elastography, Update 2017 (Long Version) 96
Long-term beta-blockade shortens QT interval prolongation in patients with liver cirrhosis 96
Benefits, Open questions and Challenges of the use of Ultrasound in the COVID-19 pandemic eraThe views of a panel of worldwide international experts 93
Systemic endothelial function evaluated by flow-mediated dilatation of brachial artery in patients with liver disease 90
Prevalence and factors associated with fatty liver in a geriatric population: results from the Pianoro Study. 90
Spleen enlargement on follow-up evaluation: a noninvasive predictor of complications of portal hypertension in cirrhosis 90
Plasma total homocysteine and cardiovascular risk in patients submitted to liver transplantation. 89
null 88
Portal hypertension and liver cirrhosis in rats: effect of the beta3-adrenoceptor agonist SR58611A. 85
Effetti dell’allenamento aerobico sui fattori di rischio cardiovascolare e sullo stato cognitivo dell’anziano 85
Transjugular intrahepatic portosystemic shunt placement for refractory ascites: a single-centre experience 80
2D shear wave liver elastography by Aixplorer to detect portal hypertension in cirrhosis: An individual patient data meta-analysis 80
Natural history of formation and growth of oesophageal varices 71
null 71
Liver stiffness predicts the development of portal hypertension related complications in advanced chronic liver disease 68
Splanchnic hemodynamics in non-alcoholic fatty liver disease: effect of a dietary/ pharmachological treatment. A pilot study 54
null 54
Guidelines and Good Clinical Practice Recommendations for Contrast-Enhanced Ultrasound (CEUS) in the Liver–Update 2020 WFUMB in Cooperation with EFSUMB, AFSUMB, AIUM, and FLAUS 49
Non-cardiac determinants of NT-proBNP levels in the elderly: relevance of hematocrit and hepatic steatosis. 48
Validation of a standardized CT protocol for the evaluation of varices and porto-systemic shunts in cirrhotic patients 46
Torsade de pointes during amiodarone infusion in a cirrhotic patient with a prolonged QT interval. 44
A combined model based on spleen stiffness measurement and Baveno VI criteria to rule out high-risk varices in advanced chronic liver disease 30
Quantification of Liver Fat Content with Ultrasound: A WFUMB Position Paper 26
Isolated hepatic tuberculoma after orthotopic liver transplantation: a case report 19
Plasma total homocysteine and cardiovascular risk in patients submitted to liver transplantation. 18
PREVENTION OF AGE-RELATED COGNITIVE DECLINE BY LONG TERM AEROBIC TRAINING 5
Accuracy of spleen stiffness measurement for the diagnosis of clinically significant portal hypertension in patients with compensated advanced chronic liver disease: a systematic review and individual patient data meta-analysis 4
Comments and illustrations of the WFUMB CEUS liver guidelines: Rare benign focal liver lesion, part II 1
Comments and illustrations of the WFUMB CEUS liver guidelines: Rare benign focal liver lesion, part I 1
Focal liver lesions other than hepatocellular carcinoma in cirrhosis: Diagnostic challenges 1
Totale 4.408
Categoria #
all - tutte 10.789
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.789


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201960 0 0 0 0 0 0 0 0 0 0 18 42
2019/20201.199 174 26 16 58 132 124 170 152 165 76 45 61
2020/2021624 131 44 20 32 16 28 11 34 57 22 33 196
2021/2022858 74 23 40 44 78 48 23 48 34 46 251 149
2022/20231.085 116 164 68 162 59 79 31 57 165 21 81 82
2023/2024233 9 60 16 33 15 46 10 17 7 20 0 0
Totale 4.408